Codexis, Inc. (CDXS)
NASDAQ: CDXS · Real-Time Price · USD
1.890
+0.070 (3.85%)
At close: Apr 6, 2026, 4:00 PM EDT
1.900
+0.010 (0.53%)
Pre-market: Apr 7, 2026, 8:09 AM EDT
Codexis Market Cap
Codexis has a market cap or net worth of $171.74 million as of April 7, 2026. Its market cap has decreased by -18.68% in one year.
Market Cap
171.74M
Enterprise Value
166.74M
1-Year Change
-18.68%
Ranking
Category
Stock Price
$1.89
Market Cap Chart
Since April 22, 2010, Codexis's market cap has decreased from $449.60M to $171.74M, a decrease of -61.80%. That is a compound annual growth rate of -5.85%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 6, 2026 | 171.70M | 16.64% |
| Dec 31, 2025 | 147.20M | -62.08% |
| Dec 31, 2024 | 388.20M | 82.25% |
| Dec 29, 2023 | 213.00M | -30.41% |
| Dec 30, 2022 | 306.10M | -84.91% |
| Dec 31, 2021 | 2.03B | 56.76% |
| Dec 31, 2020 | 1.29B | 38.30% |
| Dec 31, 2019 | 935.70M | 3.72% |
| Dec 31, 2018 | 902.10M | 123.46% |
| Dec 29, 2017 | 403.70M | 112.92% |
| Dec 30, 2016 | 189.60M | 11.20% |
| Dec 31, 2015 | 170.50M | 71.01% |
| Dec 31, 2014 | 99.70M | 87.05% |
| Dec 31, 2013 | 53.30M | -35.78% |
| Dec 31, 2012 | 83.00M | -56.43% |
| Dec 30, 2011 | 190.50M | -47.49% |
| Dec 31, 2010 | 362.80M | -19.31% |
| Apr 22, 2010 | 449.60M | - |
View and export this data all the way back to 2010. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Artiva Biotherapeutics | 180.18M |
| Corbus Pharmaceuticals Holdings | 179.85M |
| Protalix BioTherapeutics | 178.06M |
| Achieve Life Sciences | 171.97M |
| Galectin Therapeutics | 168.52M |
| Nkarta | 168.25M |
| Sagimet Biosciences | 167.49M |
| Unicycive Therapeutics | 167.07M |